Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Marburgvirus Infection Market Status and Forecast (2016-2027)
1.3.2 Global Marburgvirus Infection Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Marburgvirus Infection Supply by Company
2.1 Global Marburgvirus Infection Sales Value by Company
2.2 Marburgvirus Infection Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Marburgvirus Infection Market Status by Type
3.1 Marburgvirus Infection Type Introduction
3.1.1 Eritoran Tetrasodium
3.1.2 AR-12
3.1.3 ARD-5
3.1.4 AVI-7288
3.1.5 Others
3.2 Global Marburgvirus Infection Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Marburgvirus Infection Market Status by Application
4.1 Marburgvirus Infection Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Marburgvirus Infection Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Marburgvirus Infection Market Status by Region
5.1 Global Marburgvirus Infection Market by Region
5.2 North America Marburgvirus Infection Market Status
5.3 Europe Marburgvirus Infection Market Status
5.4 Asia Pacific Marburgvirus Infection Market Status
5.5 Central & South America Marburgvirus Infection Market Status
5.6 Middle East & Africa Marburgvirus Infection Market Status
6 North America Marburgvirus Infection Market Status
6.1 North America Marburgvirus Infection Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Marburgvirus Infection Market Status
7.1 Europe Marburgvirus Infection Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Marburgvirus Infection Market Status
8.1 Asia Pacific Marburgvirus Infection Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Marburgvirus Infection Market Status
9.1 Central & South America Marburgvirus Infection Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Marburgvirus Infection Market Status
10.1 Middle East & Africa Marburgvirus Infection Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Marburgvirus Infection Market Forecast by Type and by Application
12.1 Global Marburgvirus Infection Sales Value Forecast (2022-2027)
12.2 Global Marburgvirus Infection Forecast by Type
12.3 Global Marburgvirus Infection Forecast by Application
13 Global Marburgvirus Infection Market Forecast by Region/Country
13.1 Global Marburgvirus Infection Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Theravectys SA
14.1.1 Company Information
14.1.2 Marburgvirus Infection Product Introduction
14.1.3 Theravectys SA Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Sarepta Therapeutics Inc
14.2.1 Company Information
14.2.2 Marburgvirus Infection Product Introduction
14.2.3 Sarepta Therapeutics Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Rodos BioTarget GmbH
14.3.1 Company Information
14.3.2 Marburgvirus Infection Product Introduction
14.3.3 Rodos BioTarget GmbH Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Profectus BioSciences Inc
14.4.1 Company Information
14.4.2 Marburgvirus Infection Product Introduction
14.4.3 Profectus BioSciences Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 NanoViricides Inc
14.5.1 Company Information
14.5.2 Marburgvirus Infection Product Introduction
14.5.3 NanoViricides Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Johnson & Johnson
14.6.1 Company Information
14.6.2 Marburgvirus Infection Product Introduction
14.6.3 Johnson & Johnson Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Integrated BioTherapeutics Inc
14.7.1 Company Information
14.7.2 Marburgvirus Infection Product Introduction
14.7.3 Integrated BioTherapeutics Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Fab'entech SA
14.8.1 Company Information
14.8.2 Marburgvirus Infection Product Introduction
14.8.3 Fab'entech SA Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Emergent BioSolutions Inc
14.9.1 Company Information
14.9.2 Marburgvirus Infection Product Introduction
14.9.3 Emergent BioSolutions Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Eisai Co Ltd
14.10.1 Company Information
14.10.2 Marburgvirus Infection Product Introduction
14.10.3 Eisai Co Ltd Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 BioCryst Pharmaceuticals Inc
14.12 Arno Therapeutics Inc
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Marburgvirus Infection Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Marburgvirus Infection Sales Value (Million USD) by Company (2019-2021)
Table Global Marburgvirus Infection Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Marburgvirus Infection Sales Area
Table Marburgvirus Infection Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Marburgvirus Infection Sales Value (Million USD) by Type (2016-2021)
Table Global Marburgvirus Infection Sals Value Market Share by Type (2016-2021)
Table North America Marburgvirus Infection Sales Value (Million USD) by Type (2016-2021)
Table North America Marburgvirus Infection Sales Value Market Share by Type (2016-2021)
Table Europe Marburgvirus Infection Sales Value (Million USD) by Type (2016-2021)
Table Europe Marburgvirus Infection Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Marburgvirus Infection Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Marburgvirus Infection Sales Value Market Share by Type (2016-2021)
Table Central & South America Marburgvirus Infection Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Marburgvirus Infection Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Marburgvirus Infection Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Marburgvirus Infection Sales Value Market Share by Type (2016-2021)
Table Global Marburgvirus Infection Sales Value (Million USD) by Application (2016-2021)
Table Global Marburgvirus Infection Value Market Share by Application (2016-2021)
Table North America Marburgvirus Infection Sales Value (Million USD) by Application (2016-2021)
Table North America Marburgvirus Infection Sales Value Market Share by Application (2016-2021)
Table Europe Marburgvirus Infection Sales Value (Million USD) by Application (2016-2021)
Table Europe Marburgvirus Infection Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Marburgvirus Infection Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Marburgvirus Infection Sales Value Market Share by Application (2016-2021)
Table Central & South America Marburgvirus Infection Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Marburgvirus Infection Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Marburgvirus Infection Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Marburgvirus Infection Sales Value Market Share by Application (2016-2021)
Table Global Marburgvirus Infection Sales Value (Million USD) by Region (2016-2021)
Table Global Marburgvirus Infection Value Market Share by Region (2016-2021)
Table North America Marburgvirus Infection Sales Value (Million USD) by Country (2016-2021)
Table North America Marburgvirus Infection Value Market Share by Country (2016-2021)
Table Europe Marburgvirus Infection Sales Value (Million USD) by Country (2016-2021)
Table Europe Marburgvirus Infection Value Market Share by Country (2016-2021)
Table Asia Pacific Marburgvirus Infection Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Marburgvirus Infection Value Market Share by Country (2016-2021)
Table Central & South America Marburgvirus Infection Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Marburgvirus Infection Value Market Share by Country (2016-2021)
Table Middle East & Africa Marburgvirus Infection Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Marburgvirus Infection Value Market Share by Country (2016-2021)
Table Global Marburgvirus Infection Value (Million USD) Forecast by Type (2022-2027)
Table Global Marburgvirus Infection Value Market Share Forecast by Type (2022-2027)
Table Global Marburgvirus Infection Value (Million USD) Forecast by Application (2022-2027)
Table Global Marburgvirus Infection Value Market Share Forecast by Application (2022-2027)
Table Global Marburgvirus Infection Value (Million USD) Forecast by Region (2022-2027)
Table Global Marburgvirus Infection Value Market Share Forecast by Region (2022-2027)
Table Theravectys SA Company Information
Table Theravectys SA Product Introduction
Table Theravectys SA Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Sarepta Therapeutics Inc Company Information
Table Sarepta Therapeutics Inc Product Introduction
Table Sarepta Therapeutics Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Rodos BioTarget GmbH Company Information
Table Rodos BioTarget GmbH Product Introduction
Table Rodos BioTarget GmbH Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Profectus BioSciences Inc Company Information
Table Profectus BioSciences Inc Product Introduction
Table Profectus BioSciences Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table NanoViricides Inc Company Information
Table NanoViricides Inc Product Introduction
Table NanoViricides Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Johnson & Johnson Company Information
Table Johnson & Johnson Product Introduction
Table Johnson & Johnson Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Integrated BioTherapeutics Inc Company Information
Table Integrated BioTherapeutics Inc Product Introduction
Table Integrated BioTherapeutics Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Fab'entech SA Company Information
Table Fab'entech SA Product Introduction
Table Fab'entech SA Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Emergent BioSolutions Inc Company Information
Table Emergent BioSolutions Inc Product Introduction
Table Emergent BioSolutions Inc Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)
Table Eisai Co Ltd Company Information
Table Eisai Co Ltd Product Introduction
Table Eisai Co Ltd Marburgvirus Infection Sales Value, Gross Margin and Global Share (2019-2021)